Heart health study for kids starting a type of chemotherapy
Part of Injuries & trauma clinical trials.
This study checks how a common chemotherapy drug (anthracycline) affects the heart in children. It will monitor heart function during treatment to help protect young patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 18 years old (child or teen).
- You have not had this type of chemotherapy before.
- You have not had a bone marrow transplant or chest radiation.
- Your heart function is normal before starting treatment.
- An echo shows no serious fluid or valve problems in your heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the heart and blood vessels are working years after childhood cancer treatment with anthracycline chemotherapy, which can sometimes affect the heart. By checking your heart function, the study aims to find any early signs of problems so that better care can be provided.
This study looks at how chemotherapy and other cancer treatments affect the heart in children. It aims to find heart problems early so they can be treated quickly.
This study follows patients receiving a type of chemotherapy called anthracyclines to track how it affects the heart over time. The goal is to learn how to better protect heart health during cancer treatment.
This study uses heart imaging scans and blood tests to check if a common cancer drug (anthracycline) is affecting your heart during treatment. Early detection might help doctors protect your heart health.
This study tracks the heart health of adults receiving chemotherapy that may affect the heart. It helps doctors understand how to better monitor and protect patients.
This trial tests whether a medication can prevent heart damage in children and teens receiving chemotherapy. It is for patients aged 2 to 18 who can take oral medication.
Hear when a new Heart Injuries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.